BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37015223)

  • 1. ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
    Jiang B; Weinstock DM; Donovan KA; Sun HW; Wolfe A; Amaka S; Donaldson NL; Wu G; Jiang Y; Wilcox RA; Fischer ES; Gray NS; Wu W
    Cell Chem Biol; 2023 Apr; 30(4):383-393.e6. PubMed ID: 37015223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.
    Wang T; Lu Y; Polk A; Chowdhury P; Murga-Zamalloa C; Fujiwara H; Suemori K; Beyersdorf N; Hristov AC; Lim MS; Bailey NG; Wilcox RA
    Clin Cancer Res; 2017 May; 23(10):2506-2515. PubMed ID: 27780854
    [No Abstract]   [Full Text] [Related]  

  • 3. Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.
    Gallagher MP; Conley JM; Vangala P; Garber M; Reboldi A; Berg LJ
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34452995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
    Zhong Y; Dong S; Strattan E; Ren L; Butchar JP; Thornton K; Mishra A; Porcu P; Bradshaw JM; Bisconte A; Owens TD; Verner E; Brameld KA; Funk JO; Hill RJ; Johnson AJ; Dubovsky JA
    J Biol Chem; 2015 Mar; 290(10):5960-78. PubMed ID: 25593320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.
    Gomez-Rodriguez J; Wohlfert EA; Handon R; Meylan F; Wu JZ; Anderson SM; Kirby MR; Belkaid Y; Schwartzberg PL
    J Exp Med; 2014 Mar; 211(3):529-43. PubMed ID: 24534190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.
    Joseph RE; Kleino I; Wales TE; Xie Q; Fulton DB; Engen JR; Berg LJ; Andreotti AH
    Sci Signal; 2013 Aug; 6(290):ra76. PubMed ID: 23982207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.
    Liao XC; Littman DR
    Immunity; 1995 Dec; 3(6):757-69. PubMed ID: 8777721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.
    Liu Y; Wang X; Deng L; Ping L; Shi Y; Zheng W; Lin N; Wang X; Tu M; Xie Y; Liu W; Ying Z; Zhang C; Pan Z; Wang X; Ding N; Song Y; Zhu J
    Cancer Cell Int; 2019; 19():32. PubMed ID: 30814910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2-inducible T-cell kinase (ITK) finds another (dance) partner...TFII-I.
    August A
    Eur J Immunol; 2009 Sep; 39(9):2354-7. PubMed ID: 19688746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Tec protein-tyrosine kinase in T cell signaling.
    Yang WC; Ghiotto M; Barbarat B; Olive D
    J Biol Chem; 1999 Jan; 274(2):607-17. PubMed ID: 9872994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway.
    Li H; Wang C; Ma P; Zhang M; Yang H; Yuan S; Wei J; Tao L; Qian K; Xu M; Li L
    J Dermatol Sci; 2020 Mar; 97(3):208-215. PubMed ID: 32165081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 inducible T cell kinase (ITK) may participate in the anti-bacterial immune response of Nile tilapia via regulating T-cell activation.
    Liang W; Li K; Zhang Q; Li K; Ai K; Zhang J; Jiao X; Li J; Wei X; Yang J
    Fish Shellfish Immunol; 2022 Aug; 127():419-426. PubMed ID: 35779809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR/ITK Signaling in Type 1 Regulatory T cells.
    McGee MC; August A; Huang W
    Adv Exp Med Biol; 2021; 1278():115-124. PubMed ID: 33523446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase.
    Miller AT; Berg LJ
    J Immunol; 2002 Mar; 168(5):2163-72. PubMed ID: 11859102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conserved motif in the ITK PH-domain is required for phosphoinositide binding and TCR signaling but dispensable for adaptor protein interactions.
    Hirve N; Levytskyy RM; Rigaud S; Guimond DM; Zal T; Sauer K; Tsoukas CD
    PLoS One; 2012; 7(9):e45158. PubMed ID: 23028816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Itk inhibitors block T-cell activation and murine lung inflammation.
    Lin TA; McIntyre KW; Das J; Liu C; O'Day KD; Penhallow B; Hung CY; Whitney GS; Shuster DJ; Yang X; Townsend R; Postelnek J; Spergel SH; Lin J; Moquin RV; Furch JA; Kamath AV; Zhang H; Marathe PH; Perez-Villar JJ; Doweyko A; Killar L; Dodd JH; Barrish JC; Wityak J; Kanner SB
    Biochemistry; 2004 Aug; 43(34):11056-62. PubMed ID: 15323564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itk Promotes the Integration of TCR and CD28 Costimulation through Its Direct Substrates SLP-76 and Gads.
    Hallumi E; Shalah R; Lo WL; Corso J; Oz I; Beach D; Wittman S; Isenberg A; Sela M; Urlaub H; Weiss A; Yablonski D
    J Immunol; 2021 May; 206(10):2322-2337. PubMed ID: 33931484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.
    Guo W; Liu R; Ono Y; Ma AH; Martinez A; Sanchez E; Wang Y; Huang W; Mazloom A; Li J; Ning J; Maverakis E; Lam KS; Kung HJ
    Mol Pharmacol; 2012 Nov; 82(5):938-47. PubMed ID: 22899868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
    Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
    J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
    Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
    PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.